Infants recruited into the hypoglycaemia pathway included latepreterms, small or large for gestational age (SGA/LGA), infants of diabetic mother (IDM), and those born to mothers with a BMI >33 kg/m2. The pathway involves enteral milk feeds within 2 hours of birth and blood sugar monitoring at 2, 6, 12, 18, 24 and 36 hours of life.
Background: Bronchopulmonary dysplasia (BPD) is a severe chronic lung disease of preterm infants with grave short-and long-term consequences. To date there is no effective and safe therapy in clinical use. We recently showed that prophylactic treatment with interleukin 1 receptor antagonist (IL-1Ra) prevents development of murine BPD. We assess whether delayed onset and higher dose of (IL-1Ra) treatment, and a second antiinflammatory agent, protein C (PC), prevent BPD.
Method: Murine BPD was induced by perinatal inflammation and hyperoxia. Pups received daily injections of vehicle, 1200 IU/ kg PC, 10 mg/kg IL?1Ra (early or late onset) or 100 mg/kg IL-1Ra.
Results: 10 mg/kg IL-1Ra prevented BPD more effectively than treatment with 100 mg/kg IL-1Ra, but only when treatment commenced at day 1 of life (compared to controls 28% reduction in alveolar size, 34% increase in alveolar number and 21% increase in surface area-to-volume ratio). There was a nonsignificant trend to reduced BPD severity with PC (up to 18% increase in alveolar number and lung surface area, 18% decrease in alveolar size). IL?1?, IL-1Ra, soluble intercellular adhesion molecule (sICAM)-1, IL-6 and macrophage inflammatory protein (MIP)-2 emerged as main targets in the PC-regulated pulmonary immune response (downregulation by up to 89?fold).
Conclusions: Our data indicate that prophylactic treatment with low-dose IL-1Ra is necessary to prevent BPD. Moreover, as IL-1Ra and PC employ different mechanisms of action, combined IL-1Ra and PC treatment might deliver enhanced benefits over IL-1Ra alone.
Abstract Background: There are no Australian evidence based guidelines for the weaning (introduction of first solids) of preterm infants. Current guidelines for term infants recommend weaning 17-26 weeks. Earlier introduction could boost iron intake but increase obesity risk. This study aimed to determine the age of first solids in preterm infants, compared to terms.
Method: This longitudinal observational study recruited primary carers of preterm and term infants from a level 4 (of 6) NSW neonatal centre. Structured interviews on infants' feeding practices, growth and medical conditions were conducted at birth, 3, 6, 9 and 12 months corrected postnatal age. The age of weaning and proportion of infants introduced to solids <17 weeks was determined. Group differences were tested using Mann Whitney U and chi square tests.
Results: 141 preterm (n = 83) and term (n = 58) infants were included in this initial analysis. Median weaning age for preterms was 14 weeks corrected age (range 7-23 weeks). This was significantly less than the 19 weeks (range 11-26 weeks) for term infants (U = 39.9, p < 0.001). Sixty two (75%) preterms were introduced to solids <17 weeks corrected age, compared to twelve (21%) term infants (X 2 = 39.9, p < 0.001).
Conclusions:
Preterm infants are significantly more likely to be introduced to solids at an earlier corrected age than term infants. Further work, including the effects on markers of longer term health, needs to be undertaken to determine the evidence for weaning practices in this at risk population. Background: Women who choose to breast feed their preterm infant are not always able to be with their baby in hospital and need an alternative approach to feeding. Most commonly, milk (expressed breast milk or formula) is given by bottle. Whether using bottles during establishment of breast feeds is detrimental to breast feeding success is a topic of ongoing debate.
AVOIDANCE OF BOTTLES DURING THE ESTABLISHMENT OF BREAST FEEDS IN PRETERM
The objective of this updated review is to identify the effects of avoidance of bottle feeds during establishment of breast feeding on the likelihood of successful breast feeding.
Method: We used the standard methods of the Cochrane Collaboration/Cochrane Neonatal with searches current to July 2016.
Results: We included seven trials with 1152 preterm infants. Five studies used a cup-feeding strategy, one tube-feeding and one a novel teat, when supplements to breast feeds were needed. The trials were of small to moderate size, and two had high risk of attrition bias. Meta-analyses provided evidence of low to moderate quality indicating that avoiding bottles increases the extent of breast feeding on discharge home (full breast feeding typical risk ratio (RR) 1.47, 95% confidence interval (CI) 1.19 to 1.80; any breast feeding RR 1.11, 95% CI 1.06 to 1.16) and in contrast to the previous review no clear difference in length of hospital stay.
Conclusions: Evidence of low to moderate quality suggests that supplementing breast feeds by cup increases the extent and duration of breast feeding. We found insufficient evidence to recommend supplementing breast feeds with a tube alone or novel teat. Background: Rates of pre-gestational obesity and gestational diabetes mellitus (GDM) are increasing in Australia. While both are established risk factors for neonatal hypoglycemia, the additive effect of both risks on neonatal hypoglycaemia is not well understood. The aim of the study was to determine the influence of obesity on neonatal hypoglycaemia among infants born to GDM mothers at a tertiary referral centre.
THE EFFECT OF OBESITY ON NEONATAL HYPOGLYCAEMIA IN MOTHERS WITH GESTATIONAL DIABETES: A COMPARATIVE STUDY
Methods: A retrospective comparative study of 471 singleton GDM pregnancies. Participants were divided into obese (BMI > 30 kg/m2) and not obese (BMI < 30 kg/m2) groups according to self-reported pre-pregnancy weight. Perinatal outcomes and details of hypoglycemic episodes were obtained by reviewing medical records.
Results: 25% (104/410) of the GDM mothers were obese while 36% (146/410) exceeded pregnancy weight gain recommendations. GDM and obesity resulted in a greater frequency of neonatal hypoglycaemia as compared to women with GDM alone (obese 44%, not obese 34%, p = 0.046). Obesity increased the likelihood of having multiple hypoglycaemic episodes (p = 0.022). Additionally, excess weight gain increased the likelihood of the neonate requiring Intravenous dextrose (p = 0.0012). No differences were found in the likelihood of NICU admissions or lowest plasma glucose levels.
Conclusions: Pre-pregnancy obesity and weight gain during pregnancy above the recommended limits increase the likelihood and severity of neonatal hypoglycaemia among infants of GDM mothers. The data supports earlier community based interventions to reduce obesity in women of childbearing age and targeted antenatal weight management during pregnancy as essential to improving outcomes of GDM pregnancies. The University of Queensland, Brisbane, Australia Email: Megan.Cooper@unisa.edu.au Background: The use of water immersion (WI) for labour and birth is a controversial option that is proving effective in reducing intervention and improving birth outcomes. However, Australian policies and guidelines for WI use during labour and/or birth often limit a woman's ability to make an informed decision.
Method: A three phased mixed methods approach was used and included a critical discourse analysis of Australian WI policies/guidelines, semi-structured interviews with policy/guideline informants and a survey of 245 Australian midwives' experiences of using WI. The aim was to determine how policies/guidelines were informed and to what extent if any, they facilitated the practice, particularly in regards to women's choice.
Results: Policies and guidelines referred to the benefits of water immersion whilst suggesting that the option promoted normality. Despite this, these same documents appeared to restrict the practice by reflecting commonly held concerns that are yet to be substantiated rigorous evidence. Whilst midwives identified that women were more likely to have a positive birth experience and practitioners, who had experienced WI, were more likely to support and facilitate the option, the ability for women to use water during labour and/or birth was limited.
Conclusion: Water may assist practitioners to restore their belief and trust in birth as a process, whilst facilitating women's choice and chances of a normal, natural birth.
COUNSELLING IN FETAL MEDICINE: HETEROKARYOTYPIC MONOZYGOTIC TWINS
Elizabeth Correy* Westmead Hospital Monozygotic twin pregnancies are derived from a single, fertilised egg to form two separate embryos that share the same genetic information. Monozygotic twins with differing karyotypes have been described in the literature, both discordant for sex and other chromosomal abnormalities. This rare phenomenon poses significant challenges for clinicians when counselling women and their families. We report on a case of confirmed monochorionic, diamniotic twins at twelve-week ultrasound that were found to be discordant for sex in utero. This review aims to provide relevant, evidence-based answers to common questions and issues pertaining to counselling; including diagnosis and prognosis of heterokaryotypic monozygotic twins. A systematic literature search was conducted and all reports and references lists of articles were obtained. Previous studies suggest early amniocentesis of both sacs if structural abnormalities are identified on ultrasound scan, referral for genetic counselling and consideration of selective fetal termination to improve the outcome of the structurally normal fetus. In this particular case, amniocentesis was declined, highlighting the limitations in alternative management in current published reports. The large degree of ambiguity within this area has proven to make way for difficult antenatal
